Mutual mistrust: FDA staff wary as Høeg becomes top drug regulator
WASHINGTON — In 2008, Tracy Beth Høeg, then a resident physician and ultramarathon runner, expressed dismay at vice…
FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
Big Pharma’s ‘patient advocacy’ needs to remember patients’ needs
Every year, pharmaceutical companies spend millions on “patient advocacy.” At its best, this supports families, advances science, and…
FDA moves to ease path for biosimilars as Trump seeks to cut drug costs – statnews.com
FDA moves to ease path for biosimilars as Trump seeks to cut drug costs statnews.com US FDA proposes moves…
Eli Lilly, Sarepta, Pfizer, Medicare, Novo: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Health Care Inc.: STAT investigates hospital infections reporting
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. ~*~*~Don’t talk to…
How a change in FDA guidance might revolutionise MASH drug development
Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…
MD Anderson and Phoenix to advance cell and gene therapy tech
MD Anderson will have exclusive access to the new rimiducid formulation to be used with its inducible switch…
Health care CEO salaries, UnitedHealth’s busy week
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…